Michael A. Narachi
2009
In 2009, Michael A. Narachi earned a total compensation of $3.2M as President, Chief Executive Officer and Member of the Board of Directors at Orexigen Therapeutics.
Compensation breakdown
| Bonus | $243,000 |
|---|---|
| Option Awards | $2,407,500 |
| Salary | $339,231 |
| Other | $257,580 |
| Total | $3,247,311 |
Narachi received $2.4M in option awards, accounting for 74% of the total pay in 2009.
Narachi also received $243K in bonus, $339.2K in salary and $257.6K in other compensation.
Rankings
In 2009, Michael A. Narachi's compensation ranked 1,376th out of 9,885 executives tracked by ExecPay. In other words, Narachi earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,376 out of 9,885 | 86th |
Division Manufacturing | 487 out of 3,690 | 87th |
Major group Chemicals And Allied Products | 100 out of 866 | 89th |
Industry group Drugs | 65 out of 638 | 90th |
Industry Pharmaceutical Preparations | 53 out of 446 | 88th |
Source: SEC filing on April 27, 2012.
Narachi's colleagues
We found seven more compensation records of executives who worked with Michael A. Narachi at Orexigen Therapeutics in 2009.
2009
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2009
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2009
Dawn Viveash
Orexigen Therapeutics
Senior Vice President, Regulatory Affairs
2009
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2009
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2009
Heather Turner
Orexigen Therapeutics
General Counsel
2009
Eckard Weber
Orexigen Therapeutics